Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 70 entries
View as:

A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT05906992 Org: User:
Start: 01/11/24 End: 01/31/29 Due: 01/31/30

A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05993806 Org: User:
Start: 06/02/23 End: 06/29/23 Due: 06/29/24

This is a Phase 1 Study to Evaluate the Safety,Tolerability and Virology of CT P59 in Patients With Mild Symptoms of Symptoms of Coronavirus Disease (COVID-19)

Phase: N/A Priority: Normal
NCT ID: NCT04593641 Org: User:
Start: 09/04/20 End: 04/05/21 Due: 04/05/22

A Study to Compare Pharmacokinetics, Efficacy and Safety of Subcutaneous CT-P44 and Darzalex Faspro in Combination With Lenalidomide and Dexamethasone in Patients With Refractory or Relapsed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT06952478 Org: User:
Start: 05/31/25 End: 06/25/29 Due: 06/25/30

A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT04757376 Org: User:
Start: 06/17/21 End: 11/16/23 Due: 11/16/24

Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in RA Patients(PLANETRA)

Phase: N/A Priority: Normal
NCT ID: NCT01217086 Org: User:
Start: 10/31/10 End: 07/31/12 Due: 07/31/13

A Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT06738719 Org: User:
Start: 01/03/25 End: 04/15/26 Due: 04/15/27

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05017168 Org: User:
Start: 10/11/21 End: 01/25/22 Due: 01/25/23

A Bioequivalence Study of L04TD2 Compared to Administration of L04RD1 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05581693 Org: User:
Start: 09/30/22 End: 11/29/22 Due: 11/29/23

To Evaluate the Safety and Efficacy of Inhaled CT-P63 and CT-P66 Combination Therapy in Symptomatic Patients With COVID-19 Not Requiring Supplemental Oxygen

Phase: N/A Priority: Normal
NCT ID: NCT05224856 Org: User:
Start: 04/30/22 End: 01/31/23 Due: 01/31/24

An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT02557308 Org: User:
Start: 05/26/15 End: 02/28/21 Due: 02/28/22

To Compare Efficacy and Safety Between CT-P10 and Rituxan in Patients With Low Tumour Burden Follicular Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02260804 Org: User:
Start: 11/09/15 End: 09/04/19 Due: 09/04/20

A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps

Phase: N/A Priority: Normal
NCT ID: NCT05866614 Org: User:
Start: 01/13/23 End: 03/31/27 Due: 03/31/28

Program evaLuating the Autoimmune Disease iNvEstigational Drug cT-p13 in AS Patients(PLANETAS)

Phase: N/A Priority: Normal
NCT ID: NCT01220518 Org: User:
Start: 10/31/10 End: 06/30/12 Due: 06/30/13

To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria

Phase: N/A Priority: Normal
NCT ID: NCT04426890 Org: User:
Start: 12/09/20 End: 04/27/23 Due: 04/27/24

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 or CT-G11 and Food Effect of CT-G20 in Human Participants

Phase: N/A Priority: Normal
NCT ID: NCT03918967 Org: User:
Start: 04/08/19 End: 06/06/20 Due: 06/06/21

Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin

Phase: N/A Priority: Normal
NCT ID: NCT02665637 Org: User:
Start: 12/31/15 End: 04/30/16 Due: 04/30/17

A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05002244 Org: User:
Start: 07/23/21 End: 09/13/21 Due: 09/13/22

A Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05009368 Org: User:
Start: 07/23/21 End: 10/15/21 Due: 10/15/22

A Food Effect Study of CT-L01 After Oral Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05364164 Org: User:
Start: 07/09/22 End: 07/25/22 Due: 07/25/23

To Evaluate the Safety and Efficacy of Remsima™ in Patients With Crohn's Disease (CD) or Ulcerative Colitis (UC)

Phase: N/A Priority: Normal
NCT ID: NCT02326155 Org: User:
Start: 12/08/14 End: 02/28/20 Due: 02/28/21

Study to Evaluate and Compare the Efficacy and Safety of AZM and AML Combined and Alone in Mild-to-moderate Essential Hypertensive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05385770 Org: User:
Start: 05/31/22 End: 11/30/24 Due: 11/30/25

A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT05489224 Org: User:
Start: 09/14/22 End: 11/23/23 Due: 11/23/24

Efficacy and Safety Evaluating Study of CT-P6 in Her2 Positive Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02162667 Org: User:
Start: 06/30/14 End: 10/31/18 Due: 10/31/19

A Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients with Moderate to Severe Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06630559 Org: User:
Start: 04/30/25 End: 08/31/26 Due: 08/31/27